Cargando…
Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622592/ https://www.ncbi.nlm.nih.gov/pubmed/28962591 http://dx.doi.org/10.1186/s40425-017-0280-z |
_version_ | 1783267942873432064 |
---|---|
author | Kamat, Ashish M. Bellmunt, Joaquim Galsky, Matthew D. Konety, Badrinath R. Lamm, Donald L. Langham, David Lee, Cheryl T. Milowsky, Matthew I. O’Donnell, Michael A. O’Donnell, Peter H. Petrylak, Daniel P. Sharma, Padmanee Skinner, Eila C. Sonpavde, Guru Taylor, John A. Abraham, Prasanth Rosenberg, Jonathan E. |
author_facet | Kamat, Ashish M. Bellmunt, Joaquim Galsky, Matthew D. Konety, Badrinath R. Lamm, Donald L. Langham, David Lee, Cheryl T. Milowsky, Matthew I. O’Donnell, Michael A. O’Donnell, Peter H. Petrylak, Daniel P. Sharma, Padmanee Skinner, Eila C. Sonpavde, Guru Taylor, John A. Abraham, Prasanth Rosenberg, Jonathan E. |
author_sort | Kamat, Ashish M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5622592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56225922017-10-12 Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma Kamat, Ashish M. Bellmunt, Joaquim Galsky, Matthew D. Konety, Badrinath R. Lamm, Donald L. Langham, David Lee, Cheryl T. Milowsky, Matthew I. O’Donnell, Michael A. O’Donnell, Peter H. Petrylak, Daniel P. Sharma, Padmanee Skinner, Eila C. Sonpavde, Guru Taylor, John A. Abraham, Prasanth Rosenberg, Jonathan E. J Immunother Cancer Erratum BioMed Central 2017-09-28 /pmc/articles/PMC5622592/ /pubmed/28962591 http://dx.doi.org/10.1186/s40425-017-0280-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Erratum Kamat, Ashish M. Bellmunt, Joaquim Galsky, Matthew D. Konety, Badrinath R. Lamm, Donald L. Langham, David Lee, Cheryl T. Milowsky, Matthew I. O’Donnell, Michael A. O’Donnell, Peter H. Petrylak, Daniel P. Sharma, Padmanee Skinner, Eila C. Sonpavde, Guru Taylor, John A. Abraham, Prasanth Rosenberg, Jonathan E. Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma |
title | Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma |
title_full | Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma |
title_fullStr | Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma |
title_full_unstemmed | Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma |
title_short | Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma |
title_sort | erratum to: society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of bladder carcinoma |
topic | Erratum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622592/ https://www.ncbi.nlm.nih.gov/pubmed/28962591 http://dx.doi.org/10.1186/s40425-017-0280-z |
work_keys_str_mv | AT kamatashishm erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT bellmuntjoaquim erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT galskymatthewd erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT konetybadrinathr erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT lammdonaldl erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT langhamdavid erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT leecherylt erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT milowskymatthewi erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT odonnellmichaela erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT odonnellpeterh erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT petrylakdanielp erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT sharmapadmanee erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT skinnereilac erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT sonpavdeguru erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT taylorjohna erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT abrahamprasanth erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma AT rosenbergjonathane erratumtosocietyforimmunotherapyofcancerconsensusstatementonimmunotherapyforthetreatmentofbladdercarcinoma |